FOSL1 and glioblastoma: To determine whether FOSL1 gene expression is related to patient survival, all GBM patients from The Human Protein Atlas were analyzed in a pooled setting; the 7-year overall survival (OS) rate, as revealed by the Kaplan–Meier survival curves, was significantly higher (p < 0.001; log-rank test) in those with low FOSL1 transcript levels compared with those with high expression [21].